PhD, University of California, Los Angeles
MA, University of California, Los Angeles

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, Oscar-Berman M, Surprise C, Colaneri L, Putnam M, Waters M, Richambault C. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders. J Clin Psychopharmacol. 2015 Feb; 35(1):34-42.View Related Profiles. PMID: 25427171; PMCID: PMC4276485; DOI: 10.1097/JCP.0000000000000246;
  2. Frank DA, Kuranz S, Appugliese D, Cabral H, Chen C, Crooks D, Heeren T, Liebschutz J, Richardson M, Rose-Jacobs R. Problematic substance use in urban adolescents: role of intrauterine exposures to cocaine and marijuana and post-natal environment. Drug Alcohol Depend. 2014 Sep 1; 142:181-90.View Related Profiles. PMID: 24999059; PMCID: PMC4180288; DOI: 10.1016/j.drugalcdep.2014.06.014;
  3. Rose-Jacobs R, Augustyn M, Beeghly M, Martin B, Cabral HJ, Heeren T, Richardson MA, Frank DA. Intrauterine substance exposures and Wechsler Individual Achievement Test-II scores at 11 years of age. Volnerable Children & Youth Studies. 2012; 7:186-197.
  4. Rose-Jacobs R, Soenksen S, Appugliese DP, Cabral HJ, Richardson MA, Beeghly M, Heeren TC, Frank DA. Early adolescent executive functioning, intrauterine exposures and own drug use. Neurotoxicol Teratol. 2011 May-Jun; 33(3):379-92.View Related Profiles. PMID: 21371553; PMCID: PMC3145371; DOI: 10.1016/;
  5. Applebaum AJ, Otto MW, Richardson MA, Safren SA. Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. J Clin Exp Neuropsychol. 2010 Jul; 32(6):579-89. PMID: 19890760; PMCID: PMC3638786; DOI: 10.1080/13803390903313572;
  6. Knapp CM, Sarid-Segal O, Richardson MA, Colaneri LS, Afshar M, Devine E, Streeter CC, Piechniczek-Buczek J, Ciraulo DA. Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):102-5.View Related Profiles. PMID: 20337506; PMCID: PMC4667705; DOI: 10.3109/00952991003674812;
  7. Applebaum AJ, Reilly LC, Gonzalez JS, Richardson MA, Leveroni CL, Safren SA. The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. AIDS Patient Care STDS. 2009 Jun; 23(6):455-62. PMID: 19519229; PMCID: PMC2856567; DOI: 10.1089/apc.2008.0181;
  8. Sarid-Segal O, Knapp CM, Burch W, Richardson MA, Bahtia S, DeQuattro K, Afshar M, Richambault C, Sickels L, Devine E, Ciraulo DA. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers. Am J Drug Alcohol Abuse. 2009; 35(5):316-9.View Related Profiles. PMID: 19637104; PMCID: PMC4028067; DOI: 10.1080/00952990903060150;
  9. Applebaum AJ, Richardson MA, Brady SM, Brief DJ, Keane TM. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS Behav. 2009 Feb; 13(1):60-5.View Related Profiles. PMID: 18690532; DOI: 10.1007/s10461-008-9441-x;
  10. Berger-Greenstein JA, Cuevas CA, Brady SM, Trezza G, Richardson MA, Keane TM. Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care STDS. 2007 Dec; 21(12):942-55.View Related Profiles. PMID: 18154491
Showing 10 of 22 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 6 publications over 4 distinct years, with a maximum of 2 publications in 1992 and 1997


Contact for Mentoring: